PNC Financial Services Group’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-8,851
Closed -$472K 4745
2016
Q1
$472K Buy
8,851
+1,617
+22% +$119K ﹤0.01% 1577
2015
Q4
$817K Buy
7,234
+6,874
+1,909% +$757K ﹤0.01% 1296
2015
Q3
$43K Buy
360
+134
+59% +$17.5K ﹤0.01% 2964
2015
Q2
$17K Sell
226
-9
-4% -$590 ﹤0.01% 3587
2015
Q1
$14K Sell
235
-949
-80% -$40.3K ﹤0.01% 3675
2014
Q4
$38K Buy
1,184
+1,084
+1,084% +$32.5K ﹤0.01% 2909
2014
Q3
$2K Sell
100
-17,040
-99% -$346K ﹤0.01% 3790
2014
Q2
$304K Buy
17,140
+4,659
+37% +$75K ﹤0.01% 1700
2014
Q1
$250K Buy
+12,481
New +$242K ﹤0.01% 1776

Other funds holding ANAC

PNC Financial Services Group's ANAC Position: Q2 2016 in Review

PNC Financial Services Group sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 8,851 shares — an estimated $472K sold.

PNC Financial Services Group first reported a position in ANAC in Q1 2014 and held it in 9 quarters. The position peaked at $817K in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • PNC Financial Services Group reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • PNC Financial Services Group sold 8,851 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $472K.
  • PNC Financial Services Group first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2014 and held it in 9 quarters.
  • PNC Financial Services Group's ANACOR PHARMACEUTICALS INC COM position peaked at $817K in Q4 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on PNC Financial Services Group's 13F filing for Q2 2016, filed 5 Aug 2016.